Liquidia (LQDA) Cash & Equivalents (2019 - 2026)
Liquidia (LQDA) recorded quarterly Cash & Equivalents of $222.8 million in Q1 2026, up 16.84% quarter-over-quarter from $190.7 million in Q4 2025, and up 31.24% on a YoY basis from $169.8 million in Q1 2025.
Liquidia (LQDA) Cash & Equivalents (2019 - 2026) Analysis & Trends
Liquidia's Cash & Equivalents history runs 8 years deep, the most recent figure standing at $222.8 million for Q1 2026.
- In Q1 2026, Cash & Equivalents rose 31.24% year-over-year to $222.8 million; the TTM figure through Mar 2026 stood at $222.8 million (up 31.24% YoY), while the FY2025 annual figure was $190.7 million, up 8.05% from the prior year.
- Cash & Equivalents was $222.8 million for Q1 2026 at Liquidia, up from $190.7 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $222.8 million in Q1 2026 to a low of $57.8 million in Q1 2022.
- Historically, Cash & Equivalents has averaged $134.2 million across 5 years, with a median of $133.1 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Cash & Equivalents soared 168.11% in 2024, then decreased 22.94% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $93.3 million in 2022, then dropped by 10.3% to $83.7 million in 2023, then soared by 110.9% to $176.5 million in 2024, then advanced by 8.05% to $190.7 million in 2025, then gained by 16.84% to $222.8 million in 2026.
- The last three Cash & Equivalents figures came in at $222.8 million (Q1 2026), $190.7 million (Q4 2025), and $157.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.28 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 40.42 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 266.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 351.55 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 222.27 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 222.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 222.79 Mn |
| Dec 31, 2025 | 190.68 Mn |
| Sep 30, 2025 | 157.50 Mn |
| Jun 30, 2025 | 173.42 Mn |
| Mar 31, 2025 | 169.76 Mn |
| Dec 31, 2024 | 176.48 Mn |
| Sep 30, 2024 | 204.37 Mn |
| Jun 30, 2024 | 133.09 Mn |
| Mar 31, 2024 | 157.86 Mn |
| Dec 31, 2023 | 83.68 Mn |
| Sep 30, 2023 | 76.23 Mn |
| Jun 30, 2023 | 88.20 Mn |
| Mar 31, 2023 | 94.41 Mn |
| Dec 31, 2022 | 93.28 Mn |
| Sep 30, 2022 | 98.32 Mn |
| Jun 30, 2022 | 103.84 Mn |
| Mar 31, 2022 | 57.80 Mn |
| Dec 31, 2021 | 57.49 Mn |
| Sep 30, 2021 | 64.05 Mn |
| Jun 30, 2021 | 67.89 Mn |